Cancer

Reimagining diagnostics: Why AI is essential for the future of NHS pathology

AI-powered pathology presents the NHS with a unique opportunity to enhance cancer detection. Paige AI explains how its tools can facilitate quicker diagnostics and improve cost efficiency within the UK’s health system.

TGF-β signalling – Tumor biology in prostate cancer

Identifying the molecular signalling pathways leading to advanced prostate cancer to improve therapy and diagnosis

New data reveals cancer diagnosis could affect treatment options

Data from Public Health England shows that cancer diagnosis could impact upon which kind of treatment a patient receives.

High-level regional event held to promote awareness and combat spread of cancer in Africa

World’s second largest inter-governmental body and First Ladies from 16 African Nations deliver Africa cancer awareness event with and agree measures to combat the spread of cancer in Africa

Be Clear on Cancer campaign urges public to ‘look before they flush’

Public Health England (PHE) is launching a national 'Be Clear on Cancer' campaign to encourage everyone to 'look before they flush' and visit their GP if they notice blood in their urine

Prevention, early detection and effective therapy in melanoma

Dr Bettina Ryll from the Melanoma Patient Network Europe gives a patient advocacy perspective

The diagnosis and treatment of cancer in the United States

The vital work of the National Cancer Institute, part of the National Institutes of Health, is placed under the spotlight here by Open Access Government, including the dissemination of new findings on the diagnosis and treatment of cancer

Prostate cancer: Enigmatic, with different shades

Professor Ghulam Nabi from the University of Dundee explores the subject of the enigmatic prostate cancer, with different shades 

Combatting the increase in skin cancer throughout Europe

The mission of the European Skin Cancer Foundation (ESCF) is placed under focus by Open Access Government, in combatting the increase in skin cancer incidence across Europe, including malignant melanoma

The role of collaboration in tackling paediatric cancer

Prof. Martin Schrappe, President of the European Society for Paediatric Oncology details the vital role of collaboration in tackling paediatric cancer across Europe

Cannabis: One of the most thoroughly studied plants ever

David Bearman, M.D., Executive VP of the American Academy of Cannabinoid Medicine details the research priorities for cannabis, one of the most thoroughly studied plants of all time 

Muscular dystrophy: Present concerns and foreseen opportunities

Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)

The challenge of curing cancer in the world’s children

Dr Martin English, Consultant Paediatric Oncologist and member of the Royal College of Paediatrics and Child Health (RCPCH) explains the challenge of curing cancer in the world’s children

Improving acute myeloid leukaemia (AML) outcomes

Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores how outcomes for acute myeloid leukaemia (AML) can be improved

At the frontier of brain tumour research, we must leave no stone unturned

With the Government set to invest an additional £20 million into the research, diagnosis and development of treatments for brain tumours, Dr Ali Hansford elaborates on the need to talk more about how we are going to find the next blockbuster treatments for these devastating diseases

Government to invest in brain cancer research in honour of Tessa Jowell

Government doubles investment in brain cancer research with £40 million 'Tessa Jowell Brain Cancer Research Mission’

Cancer immunotherapy therapy is here and now

Stephanie K. Watkins PhD from Loyola University Chicago shares her views on cancer immunotherapy therapy – the concept of using the immune system to fight and destroy cancer cells

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders